Merck ADR earnings, Revenue beat in Q3

  • Investing.com
Merck ADR earnings, Revenue beat in Q3

Investing.com - Merck (NS: PROR ) ADR reported on Friday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Merck ADR announced earnings per share of €0.5392 on revenue of €5.69B. Analysts polled by Investing.com anticipated EPS of €0.5165 on revenue of €5.57B.

Merck ADR shares are down 32.63% from the beginning of the year and are trading at €35.100 , down-from-52-week-high.They are under-performing the EUR/USD which is down 0% year to date.

Merck ADR follows other major Healthcare sector earnings this month

Merck ADR's report follows an earnings beat by Medtronic on Tuesday, August 23, 2022, who reported EPS of €1.13 on revenue of €7.37B, compared to forecasts EPS of €1.12 on revenue of €7.22B.

Agilent Technologies had beat expectations on Tuesday, August 16, 2022 with third quarter EPS of €1.34 on revenue of €1.72B, compared to forecast for EPS of €1.2 on revenue of €1.64B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles